Capricor Therapeutics Correlations

CAPR Stock

USD 13.70 0.20 1.48%

The current 90-days correlation between Capricor Therapeutics and Ideaya Biosciences is -0.09 (i.e., Good diversification). The correlation of Capricor Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Capricor Therapeutics Correlation With Market

Average diversification

The correlation between Capricor Therapeutics and DJI is 0.14 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Capricor Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Capricor Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

To learn how to invest in Capricor Stock, please use our How to Invest in Capricor Therapeutics guide.

Moving together with Capricor Stock

0.7	EQ	Equillium	Pair Corr
0.64	ME	23Andme Holding	Pair Corr
0.75	VALN	Valneva SE ADR	Pair Corr
0.78	DNLI	Denali Therapeutics	Pair Corr
0.64	DNTH	Dianthus Therapeutics	Pair Corr
0.75	DOMH	Dominari Holdings	Pair Corr
0.81	DRRX	Durect	Pair Corr
0.89	DTIL	Precision BioSciences	Pair Corr
0.89	VIGL	Vigil Neuroscience	Pair Corr
0.87	VINC	Vincerx Pharma	Pair Corr
0.87	VKTX	Viking Therapeutics	Pair Corr
0.8	VRCA	Verrica Pharmaceuticals	Pair Corr
0.8	VRDN	Viridian Therapeutics Buyout Trend	Pair Corr
0.83	VRPX	Virpax Pharmaceuticals	Pair Corr
0.69	VRTX	Vertex Pharmaceuticals	Pair Corr

Moving against Capricor Stock

0.85	DRTS	Alpha Tau Medical	Pair Corr
0.78	CDIOW	Cardio Diagnostics	Pair Corr
0.75	DMAC	DiaMedica Therapeutics	Pair Corr
0.74	VCYT	Veracyte Potential Growth	Pair Corr
0.7	VCEL	Vericel Corp Ord	Pair Corr
0.55	SABSW	SAB Biotherapeutics	Pair Corr
0.37	A	Agilent Technologies	Pair Corr
0.8	VRNA	Verona Pharma PLC	Pair Corr
0.7	DYAI	Dyadic International	Pair Corr
0.66	SRZNW	Surrozen Warrant	Pair Corr
0.61	DVAX	Dynavax Technologies	Pair Corr
0.6	VSTM	Verastem	Pair Corr

Related Correlations Analysis

	BPTH	CBIO	DFFN	NXTC	PULM	AKTX	SLNO	UNCY	CDTX	PHIO
BPTH		0.19	-0.14	-0.05	-0.27	0.24	-0.09	-0.13	-0.07	-0.23	BPTH
CBIO	0.19		-0.8	-0.89	0.56	-0.61	-0.83	0.6	0.72	-0.11	CBIO
DFFN	-0.14	-0.8		0.89	-0.62	0.69	0.76	-0.79	-0.84	0.22	DFFN
NXTC	-0.05	-0.89	0.89		-0.76	0.8	0.87	-0.81	-0.89	0.22	NXTC
PULM	-0.27	0.56	-0.62	-0.76		-0.88	-0.67	0.77	0.87	-0.36	PULM
AKTX	0.24	-0.61	0.69	0.8	-0.88		0.72	-0.83	-0.88	0.27	AKTX
SLNO	-0.09	-0.83	0.76	0.87	-0.67	0.72		-0.74	-0.79	0.2	SLNO
UNCY	-0.13	0.6	-0.79	-0.81	0.77	-0.83	-0.74		0.92	-0.27	UNCY
CDTX	-0.07	0.72	-0.84	-0.89	0.87	-0.88	-0.79	0.92		-0.39	CDTX
PHIO	-0.23	-0.11	0.22	0.22	-0.36	0.27	0.2	-0.27	-0.39		PHIO
	BPTH	CBIO	DFFN	NXTC	PULM	AKTX	SLNO	UNCY	CDTX	PHIO

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

CDTX	+ 0.92	UNCY
NXTC	+ 0.89	DFFN
SLNO	+ 0.87	NXTC
CDTX	+ 0.87	PULM
AKTX	+ 0.8	NXTC
UNCY	+ 0.77	PULM

High negative correlations

CDTX	- 0.89	NXTC
NXTC	- 0.89	CBIO
CDTX	- 0.88	AKTX
AKTX	- 0.88	PULM
CDTX	- 0.84	DFFN
UNCY	- 0.83	AKTX

Risk-Adjusted Indicators

There is a big difference between Capricor Stock performing well and Capricor Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Capricor Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
BPTH	6.48	0.31	0.05	0.12	6.36	(8.94)	7.69	(11.22)	137.94
CBIO	4.25	0.95	0.14	1.05	4.45	(6.17)	9.76	(8.33)	38.47
DFFN	2.40	(0.51)	0.00	1.66	0.00	0.00	4.09	(5.32)	12.34
NXTC	3.06	(0.80)	0.00	(0.75)	0.00	0.00	6.49	(7.45)	24.13
PULM	5.87	2.20	0.41	(1.06)	4.12	(8.05)	16.69	(5.88)	92.85
AKTX	5.39	(0.87)	0.00	1.08	0.00	0.00	10.68	(14.53)	47.27
SLNO	2.04	(0.20)	0.00	(0.15)	0.00	0.00	5.14	(4.99)	19.49
UNCY	4.53	0.85	0.14	0.62	4.68	(5.71)	14.00	(8.96)	29.86
CDTX	4.00	1.27	0.28	3.66	3.69	(4.81)	12.90	(7.85)	30.78
PHIO	11.59	2.90	0.25	0.71	10.23	(16.35)	12.33	(18.46)	336.29

Capricor Therapeutics Corporate Management

Deborah Ascheim	Chief Medical Officer	Profile
Kristi Elliott	Chief Officer	Profile
Xavier Avat	Chief Officer	Profile
MD FACC	Executive Board	Profile
Catherine Kelleher	Consultant	Profile
Eduardo Marbn	CoFounder Board	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC